Experimental study of proteasome inhibitor MG132 up-regulates Wnt/β-catenin signaling pathway to improve osteoporosis.
10.12200/j.issn.1003-0034.2022.01.012
- Author:
Rong-Xue SHAO
1
;
Liang ZHANG
1
;
He-Jie YANG
1
;
Zhi-Jing ZHANG
1
;
Jun YUE
1
;
Hao PAN
1
;
Hui ZHOU
1
;
Ren-Fu QUAN
1
Author Information
1. Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou 310007, Zhejiang, China.
- Publication Type:Randomized Controlled Trial, Veterinary
- Keywords:
Osteoporosis;
Proteasome inhibitor;
Signaling pathway;
Wnt/β-catenin
- MeSH:
Animals;
Bone Density;
Female;
Leupeptins;
Osteoporosis/drug therapy*;
Proteasome Inhibitors/pharmacology*;
Rats;
Rats, Sprague-Dawley;
Wnt Signaling Pathway;
beta Catenin/metabolism*
- From:
China Journal of Orthopaedics and Traumatology
2022;35(1):59-64
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the mechanism of proteasome inhibitor MG132 in improving osteoporosis.
METHODS:Total of 32 female SD rats, weighing 220 to 250 g and 8 weeks old, were selected. They were randomly divided into 4 groups(n=8). Rats of group A and group B were cut off ovaris on both sides to make model of osteoporosis, and then they were given proteasome inhibitors MG132 and dimethyl sufoxide (DMSO) respectively. Group C was a sham group and rats were given MG132. Group D was a normal group and rats were given MG132 too. The rats were killed in batches at 6 and 12 weeks after administration, and the femoral neck tissues were obtained. Relevant data were analyzed, such as pathomorphological observation, micro-CT analysis, detection of 20S proteasome activity in tissues, and expression of Wnt and β-catenin.
RESULTS:Morphological observation showed that the trabecular were slightly thinner, reticulated, and occasionally interrupted in group A, while the trabecular were obviously thinner and discontinuous in group B. And the trabecular were intact and arranged reticulated in group C and D. The analysis results of bone mineral density(BMD), bone surface(BS), bone volume/total volume(BV/TV) and trabecular thickness(Tb.Th) showed that group B was worse than other groups in all parameters at different time points(P<0.05), and group A was worse than group C and group D in BS(P<0.05), there was no significant difference in all parameters between group C and group D. RFU value of 20S proteasome in group B was significantly higher than that in other groups(P<0.05). According to the results of Western blot, the gray values of Wnt protein and β-catenin protein in group A were significantly higher than those in other groups (P<0.05).
CONCLUSION:MG-132, a ubiquitin proteasome inhibitor, can regulate Wnt/β-catenin signaling pathway by inhibiting the degradation of β-catenin protein, and delaying the occurrence and development of osteoporosis.
